BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1502480)

  • 1. Cimetidine on-demand in dyspepsia. Experience with randomized controlled single-subject trials.
    Johannessen T; Petersen H; Kristensen P; Fosstvedt D; Kleveland PM; Dybdahl J; Løge I
    Scand J Gastroenterol; 1992; 27(3):189-95. PubMed ID: 1502480
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The symptomatic effect of 1-day treatment periods with cimetidine in dyspepsia. Combined results from randomized, controlled, single-subject trials.
    Johannessen T; Kristensen P; Petersen H; Fosstvedt D; Løge I; Kleveland PM; Dybdahl J
    Scand J Gastroenterol; 1991 Sep; 26(9):974-80. PubMed ID: 1947791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of cimetidine in non-ulcer dyspepsia. Experience with a multi-cross-over model.
    Kleveland PM; Larsen S; Sandvik L; Kristensen P; Johannessen T; Hafstad PE; Sandbakken P; Løge I; Fjøsne U; Petersen H
    Scand J Gastroenterol; 1985 Jan; 20(1):19-24. PubMed ID: 3887548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of cimetidine in patients with non-ulcer dyspepsia and erosive prepyloric changes.
    Nesland AA; Berstad A
    Scand J Gastroenterol; 1985 Jun; 20(5):629-35. PubMed ID: 3895384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cimetidine in the treatment of non-ulcer dyspepsia: results of a randomized double-blind, placebo-controlled study.
    Singal AK; Kumar A; Broor SL
    Curr Med Res Opin; 1989; 11(6):390-7. PubMed ID: 2651015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled clinical trial of treatment with cimetidine for non-ulcer dyspepsia.
    Kelbaek H; Linde J; Eriksen J; Mungaard S; Moesgaard F; Bonnevie O
    Acta Med Scand; 1985; 217(3):281-7. PubMed ID: 3887851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cimetidine responders in non-ulcer dyspepsia.
    Johannessen T; Fjøsne U; Kleveland PM; Halvorsen T; Kristensen P; Løge I; Hafstad PE; Sandbakken P; Petersen H
    Scand J Gastroenterol; 1988 Apr; 23(3):327-36. PubMed ID: 3291085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomized, double-blind, placebo-controlled crossover trial of cimetidine and pirenzepine in nonulcer dyspepsia.
    Talley NJ; McNeil D; Hayden A; Piper DW
    Gastroenterology; 1986 Jul; 91(1):149-56. PubMed ID: 3519348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment with cimetidine, antacid, or placebo in patients with dyspepsia of unknown origin.
    Gotthard R; Bodemar G; Brodin U; Jönsson KA
    Scand J Gastroenterol; 1988 Jan; 23(1):7-18. PubMed ID: 3278366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled trials in gastrodyspepsia: a methodological aspect.
    Petersen H; Larsen S; Sandvik L; Kleveland PM; Løge I; Sandbakken P; Hafstad PE; Kristensen P; Johannessen T; Fjøsne U
    Scand J Gastroenterol Suppl; 1985; 109():153-8. PubMed ID: 3895387
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dyspepsia: Therapeutic response as a diagnostic tool.
    Petersen H; Løge I; Johannessen T; Fjøsne U; Kleveland PM; Kristensen P; Sandbakken P; Hafstad PE; Halvorsen T
    Scand J Gastroenterol Suppl; 1987; 128():108-13. PubMed ID: 3476994
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of cimetidine for the treatment of nonulcer dyspepsia.
    Lance P; Wastell C; Schiller KF
    J Clin Gastroenterol; 1986 Aug; 8(4):414-8. PubMed ID: 3531314
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long term cimetidine in the management of severe duodenal ulcer dyspepsia.
    Gray GR; Smith IS; Mackenzie I; Gillespie G
    Gastroenterology; 1978 Feb; 74(2 Pt 2):397-401. PubMed ID: 340329
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Omeprazole and H2-receptor antagonists in the acute treatment of duodenal ulcer, gastric ulcer and reflux oesophagitis: a meta-analysis.
    Eriksson S; Långström G; Rikner L; Carlsson R; Naesdal J
    Eur J Gastroenterol Hepatol; 1995 May; 7(5):467-75. PubMed ID: 7614110
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chewable cimetidine versus chewable antacid in dyspepsia: which provides faster pain relief?
    Parr SN
    Curr Med Res Opin; 1989; 11(9):557-66. PubMed ID: 2692970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The treatment of dyspepsia.
    Shearman DJ
    Aust Fam Physician; 1977 Aug; 6(8):1028-32. PubMed ID: 921613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of ecabet sodium on functional dyspepsia: a prospective, double-blinded, randomized, multi-center controlled trial.
    Lee JH; Kim JJ; Hahm KB; Lee DH; Kim N; Kim SK; Park JJ; Choi SR; Lee JH; Lee ST; Lee EH; Rhee JC
    World J Gastroenterol; 2006 May; 12(17):2756-61. PubMed ID: 16718764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Double blind comparison of omeprazole (40 mg od) versus cimetidine (400 mg qd) in the treatment of symptomatic erosive reflux oesophagitis, assessed endoscopically, histologically and by 24 h pH monitoring.
    Dehn TC; Shepherd HA; Colin-Jones D; Kettlewell MG; Carroll NJ
    Gut; 1990 May; 31(5):509-13. PubMed ID: 2190864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between active peptic ulcer, endoscopic duodenitis and symptomatic state after treatment with cimetidine.
    Danielsson A; Ek B; Nyhlin H; Steen L
    Ann Clin Res; 1980 Feb; 12(1):4-12. PubMed ID: 6990861
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.